Patents

Commentary: Abuse of U.S. patent system drives high drug prices

Modern Healthcare

By Adding Patents, Drugmaker Keeps Cheaper Humira Copies Out of U.S.

The Wall Street Journal

Want Transparent Drug Prices? End Pharma’s Patent Abuse

Morning Consult

Lawsuit: AbbVie Used Kickbacks and Nurse Ambassadors to Boost Humira Sales

The Center for Biosimilars

AbbVie is accused of paying kickbacks, using a stealthy network of nurses to promote Humira

STAT

California Sues AbbVie Over Alleged Arthritis Drug Kickbacks

Bloomberg

High drug prices: America’s migraine (and how to fix it)

The Philadelphia Tribune

Submission to FTC on the Role of Intellectual Property

A Chinese twist in the tale involving Hepatitis C drug Sofosbuvir

The Hindu Business Line

Gilead loses key patent claims for Sovaldi in China, opening door to earlier generic entry

Endpoints News